A new role for pharmacists in the personalized treatment of cancer patients?
MONARCH 3 study: CDK4/6 inhibitors in the treatment of metastatic breast cancer
Angelo Di Leo
How will the results of the SPARTAN study impact US clinical practice in prostate cancer?
Osteomimicry in prostate cancer: current understanding & future targeting
Straightforward study design: SPARTAN trial of apalutamide for nmCRPC